Histological Analysis of AlloMend® Acellular Dermal Matrix Used in Breast Implant Surgeries

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-05-17

Study Completion Date

2026-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective, histologic analysis of biopsied tissue obtained from participants who have undergone a pre-pectoral breast reconstruction or augmentation surgery with expander placement and AlloMend® Acellular Dermal Matrix.

AlloMend® Acellular Dermal Matrix graft incorporation with surrounding native soft tissue using histological assays characterizing host cell infiltration, neovascularization, inflammation, and host replacement of ADM collagen will be studied.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Retrospective Study of AlloMend Acellular Dermal Matrix (ADM) Allograft and Pre-Pectoral Breast Reconstruction

NCT06853964

Pre-Pectoral Breast Reconstruction Following Mastectomy

ACTIVE_NOT_RECRUITING

AlloMend Acellular Dermal Matrix Allograft in Pre-Pectoral Breast Reconstruction

NCT06512259

Pre-Pectoral Breast Reconstruction Following Single or Double Mastectomy

RECRUITING

Incorporation of AlloMaxTM in Breast Reconstruction Ver8-15-12

NCT01679223

Breast Cancer

UNKNOWN

Evaluating AlloMax in Immediate Expander-Based Breast Reconstruction Study

NCT01372917

Malignant Neoplasm of the Breast Acquired Absence of the Breast

COMPLETED

Comparing AlloDerm and DermACELL in Breast Reconstruction

NCT04710537

Acellular Dermal Matrix in Breast Reconstruction

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to evaluate the incorporation of AlloMend® Acellular Dermal Matrix with native surrounding tissue by obtaining up to three, 1 cm diameter biopsies per breast. The samples will then be transported to AlloSource Research and Development Labs for slide preparation and histologic analysis.

This study will be performed at one (1) clinical center in the United States.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Implant; Complications, Infection or Inflammation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥18 years of age;
* AlloMend® Acellular Dermal Matrix used during the initial prepectoral placement of tissue expanders for breast reconstruction;
* Is scheduled or will be scheduled for a procedure to exchange the tissue expander for permanent breast implant;
* Can understand the requirements of the study, has provided written, informed consent, and to comply with the study protocol.

Exclusion Criteria

* Mentally compromised (e.g., being currently treated for a psychiatric disorder, senile dementia, Alzheimer's disease) in a manner that would compromise his or her ability to consent to participate in the clinical study;
* Subjects who, in the opinion of the investigator, would not be able or willing to comply with the protocol.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes